| NDAs, ANDAs, Patents, and Exclusivity |
Food and Drug Law Institute |
2005 |
| Regulatory Liability Based on Support for CME |
Medical Education Congress |
2005 |
| Disseminating Product Information Prior to Approval |
American Conference Institute |
2004 |
| Current Issues in Regulation of Continuing Medical Education |
Drug Information Association |
2004 |
| FDA Regulation of Marketing, |
Food and Drug Law Institute |
2004 |
| Product Life Cycle Management |
Pharmaceutical Education Association |
2004 |
| Current Issues in FDA Regulation of Prescription Drug Promotion |
Drug Information Association |
2003 |
| FDA Regulation of Drug Marketing |
Drug Information Association |
2002 |
| Constitutional Limitations on FDA Regulation of Promotion |
Federalist Society |
2002 |
| FDA’s First Amendment Review |
Food and Drug Law Institute |
2002 |
| Industry-Supported Information on Therapeutic Products |
American Medical Association |
2001 |
| Pre-Approval Promotion: How to Do It Legally |
Drug Information Association |
2001 |
| Current FDA Enforcement of Drug Advertising Requirements |
Drug Information Association |
2001 |
| Federal Regulation of Drug Information on the Internet |
American Conference Institute |
2000 |
| Current FDA Enforcement of Drug Advertising Requirements |
Drug Information Association |
2000 |
| Constitutional Challenges to FDA Implementation of FDAMA |
Drug Information Association |
2000 |
